CELLINK
Swedish bioprinting firm CELLINK has announced it has formed an alliance with Swiss chemicals and biotech company Lonza. Through the agreement, the partners will combine CELLINK’s 3D bioprinting systems and…
Bioprinting company CELLINK has announced it has entered into an agreement with life science company cytena GmbH to acquire all of the company’s shares for €30.25 million (roughly $33.87 million).…
The very niche subsegment of 3D bioprinting in space has had a development that we’re excited to report: Swedish bioprinting company CELLINK recently announced that it sent 3D bioprinted stem…
Vladimir Mironov, Chief Scientific Officer at 3D Bioprinting Solutions (3D Bio) and Leading Scientist at Regenerative Medicine Institute of the Moscow Sechenov Medical University, Russia will be the main instructors…
Bioprinting company CELLINK is continually striving to advance the possibilities of additive manufacturing in the medical, and specifically bioprinting, field. To highlight its efforts, the company recently hosted a Collaborative Partnership Conference…
After INKing a number of high profile collaboration deals, CELLINK is now launching yet another a partnership with Volumetric, a Texas-based startup. The two companies will combine their expertise to…
-
Swedish bioprinting company CELLINK has received SEK 10 million in funding (roughly €965,775) from the EU to pursue a bioink development project in collaboration with the Academisch Centrum Tandheelkunde Amsterdam…
Swedish bioprinting company CELLINK has entered into a partnership with organ and tissue engineering company Prellis Biologics, Inc. with the goal of commercializing high-resolution holographic bioprinting technology for micro-scale printing.…
Swedish 3D bioprinter manufacturer CELLINK is launching a brand new bioink containing BIOLAMININ, that will enable scientists to combine the unique properties of the laminin protein with culturing cells in…
CELLINK, the Swedish startup that created one of the first universal bioinks and manufacturers cost effective bioprinters, is working on a EU co-funded project called TumorPrint. The project aims to develop…
